-
If you are a current long term investor in MannKind Corporation (NASDAQ:MNKD) shares, including those who purchased (also) prior to June 2010 their MNKD shares and presently continue to hold those shares, and/ or if you have any information relating the investigation including those who are former employees or/and whistleblowers, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
An investor in MannKind shares filed a lawsuit on behalf of purchasers of MannKind common stock only during the period between June 25, 2010 and January 19, 2011 over alleged Securities Laws violations by MannKind Corp. in connection with the FDA approval of its diabetes drug Afrezza. Meanwhile an investigation on behalf of current long term investors of MannKind Corporation (NASDAQ: ...
You must register (for free) or login to view the entire investigation.
